Biotecnología
Biotecnología
Croda, Botanical Solution Partner on Sustainable Vaccine Adjuvant QS-21
05/06/2023 -
The two organizations share expertise to bring to market QS-21 from Quillaja saponaria plant cell culture.
Getinge Acquires High Purity New England
05/06/2023 -
Acquisition will expand Getinge’s presence in the biopharma segment.
UCB, Veeva Partner to Advance Clinical Trial Efficiency
05/06/2023 -
Will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency.
3M Invests $146M in Biopharma Filtration Technology
05/06/2023 -
Will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
PTC Therapeutics Discloses Strategic Pipeline Prioritization
05/06/2023 -
Preclinical and early research gene therapy programs discontinued.
FDA Approves Pfizer’s ABRYSVO Vax for RSV Prevention
05/06/2023 -
Decision is based on the data from the pivotal Phase 3 clinical trial in approximately 37,000 participants.
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault
05/06/2023 -
Global CDMO unifies quality content and training for greater visibility and agility.
Rentschler Biopharma, Ikarovec Partner on Gene Therapies for Ophthalmic Disease
05/06/2023 -
Rentschler will support the bioprocess development of AAV material for planned preclinical testing of Ikarovec’s novel gene therapy.
TriLink BioTechnologies Expands mRNA Manufacturing Facility
05/06/2023 -
GMP facility expected to simplify the mRNA drug substance development process.
FujiFilm Cellular Dynamics Launches Human iPSC-derived Blood-Brain Barrier Isogenic Kit
05/06/2023 -
The first-of-its-kind kit models the human blood-brain barrier and can advance drug discovery and drug development.
Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
05/06/2023 -
FDA has received adverse event reports after patients used compounded semaglutide.
Lotus Clinical Research, Veeva Expand Partnership to Accelerate Clinical Trials
05/06/2023 -
Builds on Lotus' existing use of Vault Clinical Suite to implement swifter and more connected studies.
Ongoing | Non-malignant Hematology, Neurological Disorders, and Other Indications Accelerated Approvals
05/06/2023 -
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
Novartis Buys Avrobio Gene Therapy for $88 Million
05/06/2023 -
Purchases stem cell gene therapy program for cystinosis.
FDA Roundup: May 23, 2023
05/06/2023 -
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Verified Clinical Benefit | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
05/06/2023 -
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint
GeoVax, ABL Partner to Advance cGMP Production of Vaccine Candidates
05/06/2023 -
With cGMP facilities located in the U.S. and Europe, ABL will support GeoVax’s global development programs.
G-Supress DX Pediatric Cough Drops may have incorrect drug in packaging
05/06/2023 -
FDA is alerting consumers and pharmacies to not use or sell a specific lot of over-the-counter G-Supress DX Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant Cherry Flavor,...
Un hombre con parálisis vuelve a caminar gracias a una interfaz activada por sus pensamientos
05/06/2023 -
El neurocientífico Grégoire Courtine, de la Escuela Politécnica Federal de Lausana (
Drug Shortages with CDR Emily Thakur
05/06/2023 -
In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.
Firsttrustchemicals.com - 111111 - 03/20/2019
05/06/2023 -
Finished Pharmaceuticals/Unapproved New Drug/Misbranded
